死亡辅助是一种治疗吗?
Gareth S Owen1, Maria Koniarz2, Alex Ruck Keene3
1Professsor of Psychological Medicine, Ethics and Law, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom.
International journal of law and psychiatry
|February 8, 2026
概括
协助死亡 (AD) 在法律中并没有得到一致的定义. 这项研究认为,AD不应该被归类为一种治疗,尽管一些法律和指导建议相反,以提高清晰度和政策.
科学领域:
- 生物伦理学生物伦理学
- 医疗法 法律 医疗法
- 公共卫生政策 公共卫生政策
背景情况:
- 协助死亡 (AD) 的法律和道德分类仍然是一个复杂的问题.
- 国际法规和政府指导在如何表征AD决定方面有所不同.
- 了解AD决定的性质对于心理能力评估至关重要.
研究的目的:
- 分析国际法规和政府指导中协助死亡 (AD) 决策的表征.
- 从临床伦理和法律的角度来看,规范性地评估AD是否应该被归类为治疗.
- 为未来的政策研究提供建议,以更清楚地描述AD决策.
主要方法:
- 分析国际协助死亡 (AD) 法规和相关政府指导.
- 从临床和法律角度进行规范性伦理分析,包括知情同意和医疗保健法.
- 在不同司法管辖区对AD立法进行比较的法律审查.
主要成果:
- 协助死亡 (AD) 在国际法律中具有不同的特点;32个法规中的10个将其定为医疗保健或治疗.
- 在模两可的案例中 (32项法规中的14项),政府指导往往倾向于对治疗的描述.
- 法律框架和指导的很大一部分并不一致地定义AD的性质.
结论:
- 由于临床可理解性,法律连贯性和潜在的政策影响,辅助死亡 (AD) 不应该被归类为治疗.
- 需要对AD决定进行更明确的描述,以告知未来的政策和研究.
- 建议建议改进在法律和政策背景下对AD决定的分类.
相关概念视频
Kubler Ross's Stages of Dying
1.3K
Elisabeth Kübler-Ross significantly advanced psychology's understanding of the process of dying with her influential book, On Death and Dying (1969). She focused on studying terminally ill individuals and outlined five stages commonly experienced when coping with death: denial, anger, bargaining, depression, and acceptance.
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
In denial, individuals reject the reality of their condition, often thinking, "This isn't true; I feel fine," as a way to protect themselves from...
1.3K
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Anticholinesterase Agents: Poisoning and Treatment
1.7K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K


